Thor Medical ASA banner
T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 4.89 NOK 6.54%
Market Cap: kr1.7B

Wall Street
Price Targets

TRMED Price Targets Summary
Thor Medical ASA

Wall Street analysts forecast TRMED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRMED is 4.34 NOK with a low forecast of 3.54 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
3.54 NOK
28% Downside
Average
Price Target
4.34 NOK
11% Downside
Highest
Price Target
5.25 NOK
7% Upside
Thor Medical ASA Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
28% Upside
INBK
First Internet Bancorp
27% Upside
WLFC
Willis Lease Finance Corp
10% Upside

Revenue
Forecast

2% / Year
Past Growth
739% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
2% / Year
Past Growth
739% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 12 years the compound annual growth rate for Thor Medical ASA's revenue is 2%. The projected CAGR for the next 3 years is 739%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRMED's stock price target?
Price Target
4.34 NOK

According to Wall Street analysts, the average 1-year price target for TRMED is 4.34 NOK with a low forecast of 3.54 NOK and a high forecast of 5.25 NOK.

What is Thor Medical ASA's Revenue forecast?
Projected CAGR
739%

For the last 12 years the compound annual growth rate for Thor Medical ASA's revenue is 2%. The projected CAGR for the next 3 years is 739%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett